• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Unusual phenotypic alteration of beta amyloid precursor protein (betaAPP) maturation by a new Val-715 --> Met betaAPP-770 mutation responsible for probable early-onset Alzheimer's disease.一种新的Val-715→Met βAPP-770突变导致β淀粉样前体蛋白(βAPP)成熟的异常表型改变,该突变与可能的早发性阿尔茨海默病有关。
Proc Natl Acad Sci U S A. 1999 Mar 30;96(7):4119-24. doi: 10.1073/pnas.96.7.4119.
2
Genes and mechanisms involved in beta-amyloid generation and Alzheimer's disease.参与β-淀粉样蛋白生成及阿尔茨海默病的基因与机制。
Eur Arch Psychiatry Clin Neurosci. 1999;249(6):266-70. doi: 10.1007/s004060050098.
3
Subcellular compartment and molecular subdomain of beta-amyloid precursor protein relevant to the Abeta 42-promoting effects of Alzheimer mutant presenilin 2.与阿尔茨海默病突变早老素2促进Aβ42生成作用相关的β淀粉样前体蛋白的亚细胞区室和分子亚结构域
J Biol Chem. 2001 Jun 15;276(24):21678-85. doi: 10.1074/jbc.M007989200. Epub 2001 Mar 30.
4
Overexpression of Rab11 or constitutively active Rab11 does not affect sAPPalpha and Abeta secretions by wild-type and Swedish mutated betaAPP-expressing HEK293 cells.Rab11的过表达或组成型活性Rab11不影响野生型和表达瑞典突变β-淀粉样前体蛋白(betaAPP)的HEK293细胞中可溶性淀粉样前体蛋白α(sAPPalpha)和β-淀粉样蛋白(Abeta)的分泌。
Biochem Biophys Res Commun. 2000 Sep 7;275(3):910-5. doi: 10.1006/bbrc.2000.3404.
5
Alzheimer's disease-linked mutation of presenilin 2 (N141I-PS2) drastically lowers APPalpha secretion: control by the proteasome.早老素2的阿尔茨海默病相关突变(N141I-PS2)显著降低APPα分泌:蛋白酶体的调控作用
Biochem Biophys Res Commun. 1998 Nov 9;252(1):134-8. doi: 10.1006/bbrc.1998.9619.
6
Are N- and C-terminally truncated Aβ species key pathological triggers in Alzheimer's disease?N- 和 C- 端截断的 Aβ 物种是阿尔茨海默病的关键病理触发因素吗?
J Biol Chem. 2018 Oct 5;293(40):15419-15428. doi: 10.1074/jbc.R118.003999. Epub 2018 Aug 24.
7
Alzheimer's Disease is Driven by Intraneuronally Retained Beta-Amyloid Produced in the AD-Specific, βAPP-Independent Pathway: Current Perspective and Experimental Models for Tomorrow.阿尔茨海默病由在AD特异性、β-淀粉样前体蛋白(βAPP)非依赖途径中产生并在神经元内保留的β-淀粉样蛋白驱动:当前观点及未来实验模型
Ann Integr Mol Med. 2020;2(1):90-114. doi: 10.33597/aimm.02-1007.
8
Precursor-Independent Overproduction of Beta-Amyloid in AD: Mitochondrial Dysfunction as Possible Initiator of Asymmetric RNA-Dependent βAPP mRNA Amplification. An Engine that Drives Alzheimer's Disease.阿尔茨海默病中β-淀粉样蛋白的前体非依赖性过量产生:线粒体功能障碍作为不对称RNA依赖性β-淀粉样前体蛋白(βAPP)mRNA扩增的可能引发因素。一种驱动阿尔茨海默病的机制
Ann Integr Mol Med. 2019;1(1):61-74. Epub 2019 Nov 20.
9
NFkappaB-dependent control of BACE1 promoter transactivation by Abeta42.β淀粉样蛋白42对BACE1启动子反式激活的核因子κB依赖性调控
J Biol Chem. 2008 Apr 11;283(15):10037-47. doi: 10.1074/jbc.M706579200. Epub 2008 Feb 8.
10
Proprotein convertase activity contributes to the processing of the Alzheimer's beta-amyloid precursor protein in human cells: evidence for a role of the prohormone convertase PC7 in the constitutive alpha-secretase pathway.前体蛋白转化酶活性有助于人类细胞中阿尔茨海默病β-淀粉样前体蛋白的加工:激素原转化酶PC7在组成型α-分泌酶途径中作用的证据。
J Neurochem. 1999 Nov;73(5):2056-62.

引用本文的文献

1
Key questions for the future of amyloid research in dementia: a framework for integrating complex datasets.痴呆症中淀粉样蛋白研究未来的关键问题:整合复杂数据集的框架
Mol Psychiatry. 2025 Aug 22. doi: 10.1038/s41380-025-03156-0.
2
Modeling Alzheimer's Disease: A Review of Gene-Modified and Induced Animal Models, Complex Cell Culture Models, and Computational Modeling.阿尔茨海默病建模:基因修饰和诱导动物模型、复杂细胞培养模型及计算建模综述
Brain Sci. 2025 May 5;15(5):486. doi: 10.3390/brainsci15050486.
3
Advances in the cell biology of the trafficking and processing of amyloid precursor protein: impact of familial Alzheimer's disease mutations.淀粉样前体蛋白运输和加工的细胞生物学进展:家族性阿尔茨海默病突变的影响。
Biochem J. 2024 Oct 2;481(19):1297-1325. doi: 10.1042/BCJ20240056.
4
Aβ Fragment as an Anti-Fibrillogenic and Neuroprotective Agent: Advancing toward Efficient Alzheimer's Disease Treatment.β 淀粉样肽片段作为抗纤维生成和神经保护剂:迈向高效阿尔茨海默病治疗的进展。
ACS Chem Neurosci. 2023 Mar 15;14(6):1126-1136. doi: 10.1021/acschemneuro.2c00720. Epub 2023 Mar 1.
5
Clinical characteristics and genotype-phenotype correlation analysis of familial Alzheimer's disease patients with pathogenic/likely pathogenic amyloid protein precursor mutations.具有致病性/可能致病性淀粉样前体蛋白突变的家族性阿尔茨海默病患者的临床特征及基因型-表型相关性分析
Front Aging Neurosci. 2022 Oct 14;14:1013295. doi: 10.3389/fnagi.2022.1013295. eCollection 2022.
6
Screening for Genetic Mutations Associated with Early-Onset Alzheimer's Disease in Han Chinese.汉族人群早发性阿尔茨海默病相关基因突变的筛查
Curr Alzheimer Res. 2022;19(10):724-733. doi: 10.2174/1567205020666221028112915.
7
N-Truncated Aβ Starting at Position Four-Biochemical Features, Preclinical Models, and Potential as Drug Target in Alzheimer's Disease.从第4位开始的N端截短型淀粉样β蛋白——生化特性、临床前模型及作为阿尔茨海默病药物靶点的潜力
Front Aging Neurosci. 2021 Aug 20;13:710579. doi: 10.3389/fnagi.2021.710579. eCollection 2021.
8
The role of genetics in neurodegenerative dementia: a large cohort study in South China.遗传学在神经退行性痴呆中的作用:一项中国南方的大型队列研究。
NPJ Genom Med. 2021 Aug 13;6(1):69. doi: 10.1038/s41525-021-00235-3.
9
Alzheimer's Disease: An Overview of Major Hypotheses and Therapeutic Options in Nanotechnology.阿尔茨海默病:纳米技术中的主要假说与治疗选择概述
Nanomaterials (Basel). 2020 Dec 29;11(1):59. doi: 10.3390/nano11010059.
10
Gene mutations associated with early onset familial Alzheimer's disease in China: An overview and current status.中国早发性家族性阿尔茨海默病相关基因突变:概述及现状。
Mol Genet Genomic Med. 2020 Oct;8(10):e1443. doi: 10.1002/mgg3.1443. Epub 2020 Aug 6.

本文引用的文献

1
Presenilins: structural aspects and posttranslational events.早老素:结构方面及翻译后事件
Mol Neurobiol. 1999 Jun;19(3):255-65. doi: 10.1007/BF02821716.
2
Post-transcriptional contribution of a cAMP-dependent pathway to the formation of alpha- and beta/gamma-secretases-derived products of beta APP maturation in human cells expressing wild-type and Swedish mutated beta APP.在表达野生型和瑞典突变型β淀粉样前体蛋白(β-APP)的人类细胞中,cAMP依赖途径对β-APP成熟过程中α-和β/γ-分泌酶衍生产物形成的转录后贡献。
Mol Med. 1998 Nov;4(11):715-23.
3
Proteasome inhibitors prevent the degradation of familial Alzheimer's disease-linked presenilin 1 and potentiate A beta 42 recovery from human cells.蛋白酶体抑制剂可阻止家族性阿尔茨海默病相关早老素1的降解,并增强人细胞中β淀粉样蛋白42的恢复。
Mol Med. 1998 Mar;4(3):147-57.
4
Differential effects of the swedish mutant amyloid precursor protein on beta-amyloid accumulation and secretion in neurons and nonneuronal cells.瑞典突变淀粉样前体蛋白对神经元和非神经元细胞中β-淀粉样蛋白积累和分泌的不同影响。
J Biol Chem. 1997 Dec 19;272(51):32247-53. doi: 10.1074/jbc.272.51.32247.
5
Mutations in the transmembrane domain of APP altering gamma-secretase specificity.APP跨膜结构域中的突变改变了γ-分泌酶的特异性。
Biochemistry. 1997 Dec 9;36(49):15396-403. doi: 10.1021/bi971071m.
6
Characterization of new polyclonal antibodies specific for 40 and 42 amino acid-long amyloid beta peptides: their use to examine the cell biology of presenilins and the immunohistochemistry of sporadic Alzheimer's disease and cerebral amyloid angiopathy cases.针对40和42个氨基酸长的淀粉样β肽的新型多克隆抗体的特性:其在研究早老素细胞生物学以及散发性阿尔茨海默病和脑淀粉样血管病病例免疫组织化学中的应用
Mol Med. 1997 Oct;3(10):695-707.
7
Constitutive and protein kinase C-regulated secretory cleavage of Alzheimer's beta-amyloid precursor protein: different control of early and late events by the proteasome.阿尔茨海默病β-淀粉样前体蛋白的组成性及蛋白激酶C调节的分泌性裂解:蛋白酶体对早期和晚期事件的不同调控
J Neurochem. 1997 Dec;69(6):2500-5. doi: 10.1046/j.1471-4159.1997.69062500.x.
8
Alpha-secretase-derived product of beta-amyloid precursor protein is decreased by presenilin 1 mutations linked to familial Alzheimer's disease.早老素1突变与家族性阿尔茨海默病相关,该突变会降低β淀粉样前体蛋白的α-分泌酶衍生产物水平。
J Neurochem. 1997 Dec;69(6):2494-9. doi: 10.1046/j.1471-4159.1997.69062494.x.
9
A new pathogenic mutation in the APP gene (I716V) increases the relative proportion of A beta 42(43).APP基因中的一种新的致病突变(I716V)增加了Aβ42(43)的相对比例。
Hum Mol Genet. 1997 Nov;6(12):2087-9. doi: 10.1093/hmg/6.12.2087.
10
The presenilins and Alzheimer's disease.早老素与阿尔茨海默病。
Hum Mol Genet. 1997;6(10):1639-46. doi: 10.1093/hmg/6.10.1639.

一种新的Val-715→Met βAPP-770突变导致β淀粉样前体蛋白(βAPP)成熟的异常表型改变,该突变与可能的早发性阿尔茨海默病有关。

Unusual phenotypic alteration of beta amyloid precursor protein (betaAPP) maturation by a new Val-715 --> Met betaAPP-770 mutation responsible for probable early-onset Alzheimer's disease.

作者信息

Ancolio K, Dumanchin C, Barelli H, Warter J M, Brice A, Campion D, Frébourg T, Checler F

机构信息

Institut de Pharmacologie Moléculaire et Cellulaire du Centre National de la Recherche Scientifique, UPR 411, 660 Route des Lucioles, Sophia Antipolis, 06560 Valbonne, France.

出版信息

Proc Natl Acad Sci U S A. 1999 Mar 30;96(7):4119-24. doi: 10.1073/pnas.96.7.4119.

DOI:10.1073/pnas.96.7.4119
PMID:10097173
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC22430/
Abstract

We have identified a novel beta amyloid precursor protein (betaAPP) mutation (V715M-betaAPP770) that cosegregates with early-onset Alzheimer's disease (AD) in a pedigree. Unlike other familial AD-linked betaAPP mutations reported to date, overexpression of V715M-betaAPP in human HEK293 cells and murine neurons reduces total Abeta production and increases the recovery of the physiologically secreted product, APPalpha. V715M-betaAPP significantly reduces Abeta40 secretion without affecting Abeta42 production in HEK293 cells. However, a marked increase in N-terminally truncated Abeta ending at position 42 (x-42Abeta) is observed, whereas its counterpart x-40Abeta is not affected. These results suggest that, in some cases, familial AD may be associated with a reduction in the overall production of Abeta but may be caused by increased production of truncated forms of Abeta ending at the 42 position.

摘要

我们在一个家系中鉴定出一种新的β淀粉样前体蛋白(βAPP)突变(V715M-βAPP770),它与早发性阿尔茨海默病(AD)共分离。与迄今报道的其他家族性AD相关的βAPP突变不同,V715M-βAPP在人HEK293细胞和鼠神经元中的过表达减少了总的Aβ生成,并增加了生理分泌产物APPα的回收。V715M-βAPP显著降低了HEK293细胞中Aβ40的分泌,而不影响Aβ42的生成。然而,观察到在第42位终止的N端截短的Aβ(x-42Aβ)显著增加,而其对应物x-40Aβ不受影响。这些结果表明,在某些情况下,家族性AD可能与Aβ的总体生成减少有关,但可能是由在第42位终止的截短形式Aβ生成增加所致。